FTC, FDA to enhance antitrust oversight in biologics market
By 
Jaclyn Jaeger2020-02-05T19:53:00
The Federal Trade Commission and Food and Drug Administration have signaled they will be increasing their oversight of any potential antitrust behavior in the biologics market.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefFDA bans Red No. 3 dye after decades of concerns over possible health risks
The U.S. Food and Drug Administration announced Wednesday it has revoked authorization for color additive Red No. 3 from food, beverages, and drugs. Health concerns over dye have existed since it was banned from cosmetics in 1990 after it was found that large doses led to the development of cancer ...
-
ArticleEurope’s high court strikes blow to drug companies in ‘pay-for-delay’ case
The U.K. Competition and Markets Authority won a victory in a decision by Europe’s high court, ruling GlaxosmithKline’s entering of a financial deal with industry rivals to delay the generic version of its drugs violates EU competition law.
-
News BriefCFPB, DOJ withdraw guidance to lenders considering borrowers’ immigration status
Two months after the U.S. Consumer Financial Protection Bureau proposed a rule change to narrow anti-discrimination requirements for lenders, it has reversed previous guidance on noncitizen customers looking to borrow.
More from Regulatory Policy
-
ArticleEU extends carbon border tax to 180 downstream products and targets ‘loopholes’
The EU is extending its ground-breaking carbon border adjustment mechanism, which imposes carbon pricing on raw materials imported from outside the EU, to 180 downstream products made from those materials.
-
ArticleEU vows to reform financial single market rules to unlock growth and boost investment
Financial markets thrive on consistent rules across the widest markets. This is the thinking behind the European Commission’s package of measures intended to simplify and streamline the zone’s single market for financial services.
-
ArticleEU agrees rules to make payment providers and online platforms liable for customer fraud losses
Payment service providers operating in the EU will have to cover customers’ losses from fraud if their fraud protection regimes are inadequate or poorly implemented under new EU rules.